OBJECTIVE: To evaluate some measurement properties of the Myositis Activities Profile (MAP) in adult patients with polymyositis (PM) and dermatomyositis (DM) in the United States. METHODS: To assess content validity, patients with PM/DM rated difficulty and importance of items of the MAP using a visual analog scale (VAS), range 0-10. For construct validity, consecutive patients with PM/DM performed the 6-item core set for disease activity including the manual muscle test (MMT) and the Health Assessment Questionnaire (HAQ), the Functional Index-2 (FI-2; muscle endurance), and the MAP plus disease effect on well-being on a VAS. Item fit within subscales was analyzed by Cronbach's alpha. Patients with stable disease activity filled out the MAP again 1 week later. RESULTS: The median combined difficulty and importance, 0-10, of the 31 items was 5.00 (range 2.10-5.95). One item was added, giving a 32-item MAP. Correlations between the median of subscales/single items of the MAP and the HAQ and disease effect on well-being were r(s) = 0.69 and r(s) = 0.68, respectively, with lower correlations to the MMT (r(s) = -0.35), and the FI-2 (r(s) = -0.29 to -0.47) and disease activity measures (r(s) = 0.36-0.41). Cronbach's alpha coefficients for the 4 subscales varied between 0.85 and 0.95. Weighted kappa coefficients (K(w)) ranged between 0.77 and 0.93 for the 4 subscales and between 0.74 and 0.83 for the 4 single items without systematic variations (p > 0.05). CONCLUSION: This initial validation of the MAP indicates promising measurement properties for assessing limitations in activities of daily living and participation in patients with PM/DM in the United States.
OBJECTIVE: To evaluate some measurement properties of the Myositis Activities Profile (MAP) in adult patients with polymyositis (PM) and dermatomyositis (DM) in the United States. METHODS: To assess content validity, patients with PM/DM rated difficulty and importance of items of the MAP using a visual analog scale (VAS), range 0-10. For construct validity, consecutive patients with PM/DM performed the 6-item core set for disease activity including the manual muscle test (MMT) and the Health Assessment Questionnaire (HAQ), the Functional Index-2 (FI-2; muscle endurance), and the MAP plus disease effect on well-being on a VAS. Item fit within subscales was analyzed by Cronbach's alpha. Patients with stable disease activity filled out the MAP again 1 week later. RESULTS: The median combined difficulty and importance, 0-10, of the 31 items was 5.00 (range 2.10-5.95). One item was added, giving a 32-item MAP. Correlations between the median of subscales/single items of the MAP and the HAQ and disease effect on well-being were r(s) = 0.69 and r(s) = 0.68, respectively, with lower correlations to the MMT (r(s) = -0.35), and the FI-2 (r(s) = -0.29 to -0.47) and disease activity measures (r(s) = 0.36-0.41). Cronbach's alpha coefficients for the 4 subscales varied between 0.85 and 0.95. Weighted kappa coefficients (K(w)) ranged between 0.77 and 0.93 for the 4 subscales and between 0.74 and 0.83 for the 4 single items without systematic variations (p > 0.05). CONCLUSION: This initial validation of the MAP indicates promising measurement properties for assessing limitations in activities of daily living and participation in patients with PM/DM in the United States.
Authors: Helene Alexanderson; Maria Del Grande; Clifton O Bingham; Ana-Maria Orbai; Catherine Sarver; Katherine Clegg-Smith; Ingrid E Lundberg; Yeong Wook Song; Lisa Christopher-Stine Journal: J Rheumatol Date: 2014-01-15 Impact factor: 4.666
Authors: Pierrette Baschung Pfister; Eling D de Bruin; Caroline H G Bastiaenen; Britta Maurer; Ruud H Knols Journal: PLoS One Date: 2019-06-03 Impact factor: 3.240
Authors: Floranne C Ernste; Christopher Chong; Cynthia S Crowson; Tanaz A Kermani; Orla Ni Mhuircheartaigh; Helene Alexanderson Journal: J Rheumatol Date: 2020-04-15 Impact factor: 4.666